Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Obecure recruits first patient in obesity study
“Our preliminary human study demonstrates that OBE101, comprised of betahistine, offers a promising new approach to meet that need. Betahistine has a proven safety profile and has been
“Our preliminary human study demonstrates that OBE101, comprised of betahistine, offers a promising new approach to meet that need. Betahistine has a proven safety profile and has been
The British Medical Association has said that using the opium harvests could benefit the NHS and Afghanistan if the harvests are used to legally produce diamorphine, also known
Daily use of the antidepressant medications, known as selective serotonin reuptake inhibitors (SSRIs) by adults 50 years and older had a two-fold increased risk of incident clinical fragility
Davant will be examined in combination with 5-Fluorouracil (5-FU) to treat patients with advanced bile duct and gall bladder cancer. Phase I/II results showed that Davanat, when co-administered
The company intends to launch its product during the first quarter of 2007. Azithromycin for injection is indicated for the treatment in patients who require intravenous therapy for
Under the terms of the agreement, Medarex and Compugen plan to share discovery, development and commercialization responsibilities on antibody-based therapeutics resulting from this collaboration, and share revenues generated
The review was undertaken to assess the safety of the drug, MKC-1 in a phase II trial in patients with advanced or metastatic breast cancer who have failed
The primary efficacy end point for achieving ocular anesthesia and the secondary end point for duration of anesthesia were both statistically significant for all three study drug dosages.
The marketing application is for the use of Thalidomide Pharmion in untreated multiple myeloma patients. Thalidomide Pharmion has been designated as an orphan medicinal product in the EU.
The Alzheimer's vaccine works by triggering the immune system to recognize the beta amyloid protein that abnormally builds up in the brains of Alzheimer's patients as a foreign